Evaluation of the impact of an integrated care pathway for pulmonary embolism: a quasi-experimental pre-post study.
Pulmonary embolism (PE)
anticoagulation
hospital stay
integrated care pathway (ICP)
mortality
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
05
04
2021
accepted:
16
07
2021
entrez:
18
10
2021
pubmed:
19
10
2021
medline:
19
10
2021
Statut:
ppublish
Résumé
An integrated care pathway (ICP) is intended to improve the management of prevalent resource-consuming, life-threatening diseases. The purpose of this study was to determine whether the quality of patient care improved with the establishment of a dedicated unit for pulmonary embolism (PE). A quasi-experimental pre-post study (pre: years 2010-2013; post: 2015-2020; year 2014, "washing" period) of PE patients ≥18 years (January 2010-June 2020). The intervention involved the implementation of an ICP for PE. The sample was composed of 1,142 patients (510 pre-intervention and 612 post-intervention) without significant differences between the two populations. In the post-intervention period, significant reductions were observed in the median length of hospital stay (LOS) (8 Although an ICP for PE does not reduce mortality significantly, it improves the quality of patient care.
Sections du résumé
BACKGROUND
BACKGROUND
An integrated care pathway (ICP) is intended to improve the management of prevalent resource-consuming, life-threatening diseases. The purpose of this study was to determine whether the quality of patient care improved with the establishment of a dedicated unit for pulmonary embolism (PE).
METHODS
METHODS
A quasi-experimental pre-post study (pre: years 2010-2013; post: 2015-2020; year 2014, "washing" period) of PE patients ≥18 years (January 2010-June 2020). The intervention involved the implementation of an ICP for PE.
RESULTS
RESULTS
The sample was composed of 1,142 patients (510 pre-intervention and 612 post-intervention) without significant differences between the two populations. In the post-intervention period, significant reductions were observed in the median length of hospital stay (LOS) (8
CONCLUSIONS
CONCLUSIONS
Although an ICP for PE does not reduce mortality significantly, it improves the quality of patient care.
Identifiants
pubmed: 34659804
doi: 10.21037/jtd-21-595
pii: jtd-13-09-5373
pmc: PMC8482338
doi:
Types de publication
Journal Article
Langues
eng
Pagination
5373-5382Informations de copyright
2021 Journal of Thoracic Disease. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/jtd-21-595). The authors have no conflicts of interest to declare.
Références
J Clin Epidemiol. 1992 Jun;45(6):613-9
pubmed: 1607900
Clinicoecon Outcomes Res. 2015 Aug 28;7:451-62
pubmed: 26355805
Arch Intern Med. 2010 Oct 25;170(19):1710-6
pubmed: 20975016
Am J Med. 2013 Sep;126(9):832.e13-21
pubmed: 23830539
JAMA. 1990 May 23-30;263(20):2753-9
pubmed: 2332918
Med Clin (Barc). 2003 Apr 12;120(13):496-7
pubmed: 12716543
Arch Intern Med. 2003 Jun 9;163(11):1285-93
pubmed: 12796064
Ann Intern Med. 1998 Dec 15;129(12):1044-9
pubmed: 9867760
Radiology. 1992 Nov;185(2):381-7
pubmed: 1410342
PLoS One. 2016 Feb 23;11(2):e0148348
pubmed: 26906217
Arch Intern Med. 2010 Aug 9;170(15):1383-9
pubmed: 20696966
Rev Calid Asist. 2017 Jul - Aug;32(4):234-239
pubmed: 28283260
Arch Bronconeumol. 2013 Dec;49(12):534-47
pubmed: 24041726
Heart Lung Circ. 2020 Mar;29(3):345-353
pubmed: 30910512
Cochrane Database Syst Rev. 2016 Jan 29;(1):CD007699
pubmed: 26822633
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
Respir Res. 2020 Jun 22;21(1):159
pubmed: 32571318
J Thromb Thrombolysis. 2021 Jan;51(1):217-225
pubmed: 32542527
JAMA. 2018 Oct 16;320(15):1583-1594
pubmed: 30326130
Am J Cardiol. 2019 Nov 1;124(9):1465-1469
pubmed: 31495443
Circulation. 2016 Jan 5;133(1):98-103
pubmed: 26719388
Arch Bronconeumol. 2017 Aug;53(8):432-436
pubmed: 28238515
Eur Respir J. 2014 Oct;44(4):942-50
pubmed: 24993910
Am J Med. 2013 Feb;126(2):127-32
pubmed: 23331440
Eur Respir J. 2016 Jan;47(1):203-11
pubmed: 26493784
BMJ. 1998 Sep 26;317(7162):858-61
pubmed: 9748183
Eur Respir J. 2019 Oct 9;54(3):
pubmed: 31473594
Blood Coagul Fibrinolysis. 2012 Dec;23(8):705-13
pubmed: 23080362
Kardiol Pol. 2016;74(7):650-6
pubmed: 26779849